Ajit S Arora, MD
Gastroenterology · Fresno
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 43 years
- Graduated 1983
Offices
1 location · Community Foundation Medical Group · 282 clinicians in this group
Hospitals listed: Clovis Community Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Arora’s office at (559) 323-8200 to ask if they take your plan before you enroll.
California Medical Board record
Licence A45775 · Current
Licensed to practise in California · since 1989 · expires 2029-01-31 · University of Pune, Armed Forces Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Clovis Community Medical CenterClovis, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 80% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.7 (12.1 to 17.7) · 421 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.692, Oct 2024 – Sep 2025
See every measure and the patient survey for Clovis Community Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 0 better, 6 the same, 1 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.7 (12.1 to 17.7) · 421 cases | Worse | Jan 2024 – Dec 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.692 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.97 (0.04 to 1.89) · 1,840 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.16 (0.86 to 1.45) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 217.06 (167.45 to 266.67) · 84 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 69 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.1 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.4 · 161 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14 · 507 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 798 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 336 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 3,771 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.39) · 8,649 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.08 to 0.46) · 9,146 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.46 (1.47 to 5.45) · 1,654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.19 (0.61 to 3.78) · 387 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.18 (0.7 to 3.66) · 1,578 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.47 (7.08 to 19.87) · 374 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.99 (1.37 to 8.61) · 379 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.58 (0.13 to 3.04) · 405 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.8 (0.23 to 1.38) · 8,198 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 90 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.651 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.922 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.449 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.509 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 210 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -1.5 · 152 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 58.4 · 556 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18 · 769 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 802 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (4 to 7.4) · 421 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 91 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 93 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 200 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.8 to 15.6) · 2,398 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 720 cases | No different | Jan 2024 – Dec 2024 |
What patients said (441 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$140,526
Medicare paid this office $140,526 for 608 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 151 | $29,476 | $194 |
| Biopsy of large bowel using a flexible endoscope | 166 | $13,014 | $78 |
| Return visit (30+ min) | 95 | $11,809 | $96 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 126 | $10,875 | $85 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 122 | $9,612 | $77 |
See all 17 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 151 | $29,476 | $194 |
| Biopsy of large bowel using a flexible endoscope | 166 | $13,014 | $78 |
| Return visit (30+ min) | 95 | $11,809 | $96 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 126 | $10,875 | $85 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 122 | $9,612 | $77 |
| Imaging of digestive tract done from the inside of the digestive tract | 16 | $9,538 | $596 |
| Short return visit (20+ min) | 125 | $9,090 | $63 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 37 | $6,558 | $177 |
| New patient visit (45+ min) | 52 | $6,248 | $120 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 25 | $4,493 | $180 |
| New patient visit (30+ min) | 59 | $4,002 | $68 |
| Diagnostic exam of large bowel using a flexible endoscope | 24 | $3,374 | $141 |
| Long return visit (40+ min) | 16 | $2,635 | $139 |
| New patient visit (15+ min) | 42 | $1,874 | $45 |
| Dilation of esophagus | 49 | $1,551 | $32 |
| Short return visit | 20 | $783 | $39 |
| Diagnostic exam of lower portion of large bowel using a flexible endoscope | 12 | $292 | $24 |
Procedures Medicare counted
| Colonoscopy | 183 | More than 92% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 222 | More than 92% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Biopsy of large bowel using a flexible endoscope | 139 | 146 | 180 | 199 | 170 | 167 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 172 | 120 | 174 | 175 | 143 | 152 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 128 | 125 | 127 | 134 | 123 | 125 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 131 | 88 | 137 | 123 | 100 | 128 |
| Dilation of esophagus | 54 | 37 | 49 | 45 | 45 | 49 |
| Destruction of polyp or growth of large bowel using a flexible endoscope | 95 | 65 | 56 | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
608 Original Medicare patients in 2024. Average age 73 · Under 65 4% · 85 and older 4% · Women 56% · Also on Medicaid 12% · Health risk score 1.08. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 33% · Coronary heart disease 32% · Chronic kidney disease 27% · Depression 20% · Cancer 17% · Heart failure 14% · Atrial fibrillation 14% · COPD 12% · Stroke 5% · Dementia 3%.
The office billed $1,230,819, Medicare allowed $177,535 and paid $140,526; for 1,311 services of 51 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 608 | 1,311 | 73 | 1.08 | $1,230,819 | $140,526 |
| 2023 | 746 | 1,357 | 73 | 1.07 | $1,158,020 | $136,388 |
| 2022 | 956 | 1,702 | 73 | 1.11 | $1,381,557 | $167,979 |
| 2021 | 881 | 1,986 | 73 | 1.16 | $1,822,793 | $187,523 |
| 2020 | 732 | 1,642 | 72 | 1.15 | $1,243,027 | $146,939 |
| 2019 | 955 | 2,163 | 72 | 1.15 | $1,459,368 | $203,473 |
| 2018 | 916 | 2,091 | 71 | 1.11 | $1,366,931 | $189,189 |
| 2017 | 1,113 | 2,519 | 71 | 1.10 | $1,918,403 | $225,231 |
| 2016 | 1,150 | 2,050 | 72 | 1.23 | $1,592,582 | $206,974 |
| 2015 | 891 | 1,702 | 71 | 1.29 | $896,976 | $204,957 |
| 2014 | 647 | 1,445 | 72 | 1.18 | $720,827 | $175,110 |
| 2013 | 637 | 1,326 | 71 | 1.14 | $644,447 | $165,816 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 17 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 143 | $27,658 | $193 |
| Short return visit (20+ min) | 170 | $11,982 | $61 |
| Biopsy of large bowel using a flexible endoscope | 169 | $11,953 | $70 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 58 | $10,741 | $185 |
| Return visit (30+ min) | 92 | $10,126 | $93 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 120 | $10,007 | $81 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 100 | $8,335 | $83 |
| Imaging of digestive tract done from the inside of the digestive tract | 11 | $7,155 | $650 |
| New patient visit (30+ min) | 106 | $7,062 | $67 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 27 | $4,913 | $182 |
| Diagnostic exam of large bowel using a flexible endoscope | 24 | $3,227 | $134 |
| Short return visit | 75 | $3,066 | $39 |
| New patient visit (45+ min) | 21 | $2,822 | $134 |
| Long return visit (40+ min) | 17 | $2,355 | $139 |
| New patient visit (15+ min) | 44 | $2,199 | $50 |
| New patient visit (60+ min) | 11 | $1,816 | $165 |
| Dilation of esophagus | 43 | $1,418 | $32 |
2022: 19 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 175 | $33,524 | $192 |
| New patient visit (30+ min) | 216 | $17,876 | $83 |
| Return visit (30+ min) | 137 | $14,805 | $98 |
| Biopsy of large bowel using a flexible endoscope | 199 | $14,788 | $74 |
| Short return visit (20+ min) | 175 | $13,507 | $69 |
| Telephone medical discussion with physician, 21-30 minutes | 123 | $10,427 | $80 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 131 | $10,235 | $76 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 121 | $9,940 | $81 |
| Imaging of digestive tract done from the inside of the digestive tract | 12 | $8,141 | $678 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 40 | $7,416 | $185 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 19 | $3,568 | $188 |
| Diagnostic exam of large bowel using a flexible endoscope | 24 | $3,306 | $138 |
| Short return visit | 57 | $2,273 | $40 |
| New patient visit (45+ min) | 18 | $2,255 | $125 |
| Long return visit (40+ min) | 15 | $2,182 | $136 |
| Telephone medical discussion with physician, 11-20 minutes | 27 | $1,624 | $60 |
| Dilation of esophagus | 44 | $1,377 | $31 |
| New patient visit (15+ min) | 20 | $1,153 | $58 |
| Injection beneath lining of large bowel using a flexible endoscope | 16 | $362 | $23 |
2021: 22 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 174 | $27,952 | $161 |
| Short return visit (20+ min) | 219 | $19,076 | $70 |
| Biopsy of large bowel using a flexible endoscope | 179 | $18,282 | $102 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 133 | $12,245 | $89 |
| Destruction of polyp or growth of large bowel using a flexible endoscope | 56 | $12,153 | $217 |
| New patient visit (30+ min) | 126 | $11,328 | $90 |
| Telephone medical discussion with physician, 21-30 minutes | 111 | $11,316 | $92 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 58 | $11,079 | $188 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 123 | $10,599 | $83 |
| Imaging of digestive tract done from the inside of the digestive tract | 14 | $10,330 | $738 |
| Return visit (30+ min) | 77 | $8,138 | $97 |
| Telephone medical discussion with physician, 11-20 minutes | 61 | $4,318 | $66 |
| New patient visit (45+ min) | 30 | $3,884 | $129 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 21 | $3,841 | $183 |
| Short return visit | 76 | $3,370 | $42 |
| Diagnostic exam of large bowel using a flexible endoscope | 21 | $2,985 | $142 |
| Long return visit (40+ min) | 16 | $2,282 | $143 |
| New patient visit (60+ min) | 11 | $2,041 | $186 |
| New patient visit (15+ min) | 37 | $2,038 | $55 |
| Dilation of esophagus | 49 | $1,566 | $32 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 216 | $879 | $4 |
| Injection beneath lining of large bowel using a flexible endoscope | 11 | $451 | $41 |
2020: 22 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 118 | $15,854 | $132 |
| Biopsy of large bowel using a flexible endoscope | 145 | $15,584 | $107 |
| Destruction of polyp or growth of large bowel using a flexible endoscope | 64 | $14,743 | $227 |
| Short return visit (20+ min) | 186 | $13,803 | $58 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 124 | $9,864 | $79 |
| New patient visit (30+ min) | 140 | $9,755 | $70 |
| Imaging of digestive tract done from the inside of the digestive tract | 13 | $9,560 | $735 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 86 | $7,589 | $86 |
| Return visit (30+ min) | 90 | $7,390 | $79 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 33 | $6,468 | $196 |
| New patient visit (45+ min) | 42 | $4,806 | $114 |
| Telephone medical discussion with physician, 21-30 minutes | 47 | $4,238 | $90 |
| New patient visit (60+ min) | 21 | $3,422 | $163 |
| Diagnostic exam of large bowel using a flexible endoscope | 21 | $3,294 | $157 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 15 | $2,925 | $195 |
| Long return visit (40+ min) | 29 | $2,903 | $97 |
| Telephone medical discussion with physician, 11-20 minutes | 42 | $2,887 | $61 |
| Short return visit | 58 | $2,259 | $38 |
| New patient visit (15+ min) | 28 | $1,657 | $59 |
| Dilation of esophagus | 37 | $1,242 | $34 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 174 | $683 | $4 |
| Injection beneath lining of large bowel using a flexible endoscope | 13 | $332 | $24 |
2019: 21 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 172 | $22,440 | $130 |
| New patient visit (30+ min) | 294 | $21,823 | $74 |
| Destruction of polyp or growth of large bowel using a flexible endoscope | 95 | $20,945 | $220 |
| Return visit (30+ min) | 137 | $14,481 | $84 |
| Biopsy of large bowel using a flexible endoscope | 139 | $13,988 | $101 |
| Short return visit (20+ min) | 186 | $12,328 | $55 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 129 | $12,003 | $92 |
| Imaging of digestive tract done from the inside of the digestive tract | 13 | $11,172 | $745 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 124 | $11,012 | $86 |
| New patient visit (45+ min) | 84 | $9,675 | $115 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 47 | $9,039 | $192 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 39 | $7,509 | $193 |
| New patient visit (60+ min) | 40 | $6,284 | $157 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $5,103 | $165 |
| Long return visit (40+ min) | 40 | $4,839 | $113 |
| Diagnostic exam of large bowel using a flexible endoscope | 25 | $3,608 | $144 |
| Dilation of esophagus | 53 | $1,742 | $32 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 268 | $1,073 | $4 |
| Short return visit | 27 | $977 | $36 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $947 | $59 |
| Injection beneath lining of large bowel using a flexible endoscope | 20 | $410 | $20 |
2018: 19 services
| New patient visit (30+ min) | 373 | $27,133 | $73 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 177 | $22,470 | $126 |
| Destruction of polyp or growth of large bowel using a flexible endoscope | 96 | $20,112 | $207 |
| Short return visit (20+ min) | 231 | $16,364 | $53 |
| Biopsy of large bowel using a flexible endoscope | 124 | $13,539 | $109 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 134 | $10,712 | $79 |
| Imaging of digestive tract done from the inside of the digestive tract | 13 | $10,252 | $732 |
| Return visit (30+ min) | 109 | $9,525 | $74 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 102 | $8,505 | $83 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 41 | $7,848 | $191 |
| New patient visit (45+ min) | 59 | $7,057 | $120 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 34 | $6,502 | $191 |
| New patient visit (60+ min) | 30 | $4,798 | $160 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $3,790 | $158 |
| Long return visit (40+ min) | 30 | $3,311 | $107 |
| Diagnostic exam of large bowel using a flexible endoscope | 21 | $3,139 | $149 |
| Short return visit | 46 | $1,771 | $34 |
| Dilation of esophagus | 47 | $1,589 | $33 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 192 | $834 | $4 |
2017: 21 services
| New patient visit (30+ min) | 475 | $34,729 | $73 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 140 | $18,071 | $126 |
| Destruction of polyp or growth of large bowel using a flexible endoscope | 79 | $17,420 | $215 |
| Return visit (30+ min) | 161 | $15,775 | $78 |
| Short return visit (20+ min) | 223 | $14,542 | $56 |
| Biopsy of large bowel using a flexible endoscope | 139 | $14,434 | $104 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 161 | $13,485 | $83 |
| Imaging of digestive tract done from the inside of the digestive tract | 17 | $12,181 | $717 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 57 | $10,773 | $189 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 111 | $10,345 | $90 |
| New patient visit (45+ min) | 92 | $10,294 | $112 |
| New patient visit (60+ min) | 57 | $8,881 | $156 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 46 | $8,734 | $190 |
| Long return visit (40+ min) | 54 | $6,070 | $108 |
| Diagnostic exam of large bowel using a flexible endoscope | 39 | $5,686 | $146 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $5,417 | $164 |
| Dilation of esophagus | 56 | $1,863 | $33 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $1,523 | $59 |
| Short return visit | 41 | $1,407 | $34 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 303 | $1,345 | $4 |
| Injection beneath lining of large bowel using a flexible endoscope | 14 | $493 | $35 |
2016: 19 services
| New patient visit (30+ min) | 432 | $31,541 | $73 |
| New patient visit (45+ min) | 158 | $18,861 | $119 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 125 | $18,104 | $143 |
| Return visit (30+ min) | 170 | $16,670 | $81 |
| Destruction of polyp or growth of large bowel using a flexible endoscope | 65 | $13,714 | $208 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 143 | $12,047 | $84 |
| Biopsy of large bowel using a flexible endoscope | 126 | $12,003 | $95 |
| New patient visit (60+ min) | 75 | $11,205 | $149 |
| Short return visit (20+ min) | 162 | $10,130 | $52 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 109 | $9,431 | $86 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 47 | $9,122 | $194 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 41 | $7,967 | $194 |
| Diagnostic exam of large bowel using a flexible endoscope | 50 | $7,332 | $147 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 30 | $5,145 | $161 |
| Long return visit (40+ min) | 32 | $3,750 | $110 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $1,891 | $56 |
| Dilation of esophagus | 56 | $1,879 | $34 |
| Short return visit | 28 | $938 | $34 |
| Injection beneath lining of large bowel using a flexible endoscope | 19 | $615 | $31 |
2015: 18 services
| New patient visit (45+ min) | 220 | $28,447 | $129 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 111 | $20,838 | $186 |
| Biopsy of large bowel using a flexible endoscope | 103 | $15,710 | $151 |
| New patient visit (60+ min) | 89 | $14,478 | $163 |
| Colonoscopy, flexible; proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare tehnique | 53 | $13,297 | $251 |
| New patient visit (30+ min) | 158 | $12,865 | $81 |
| Short return visit (20+ min) | 180 | $12,749 | $55 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 115 | $10,645 | $93 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 118 | $10,312 | $87 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 46 | $9,786 | $213 |
| Return visit (30+ min) | 102 | $9,048 | $82 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 40 | $8,434 | $211 |
| Diagnostic exam of large bowel using a flexible endoscope | 39 | $6,706 | $172 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,207 | $160 |
| Long return visit (40+ min) | 19 | $2,388 | $119 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $1,652 | $55 |
| Short return visit | 43 | $1,383 | $32 |
| Dilation of esophagus | 32 | $1,199 | $36 |
2014: 19 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 127 | $20,597 | $161 |
| Removal of polyps or growths in large bowel using an endoscope | 64 | $17,239 | $265 |
| New patient visit (45+ min) | 134 | $17,174 | $128 |
| Imaging of digestive tract done from the inside of the digestive tract | 17 | $13,620 | $757 |
| Short return visit (20+ min) | 192 | $13,490 | $54 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 49 | $10,711 | $219 |
| Biopsy of large bowel using a flexible endoscope | 78 | $10,233 | $130 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 115 | $10,139 | $86 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 105 | $8,694 | $83 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 38 | $8,306 | $219 |
| New patient visit (30+ min) | 107 | $8,227 | $77 |
| New patient visit (60+ min) | 40 | $6,423 | $161 |
| Return visit (30+ min) | 66 | $6,116 | $84 |
| Diagnostic exam of large bowel using a flexible endoscope | 37 | $6,037 | $163 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,269 | $163 |
| Short return visit | 48 | $1,642 | $32 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,105 | $58 |
| Dilation of esophagus | 21 | $759 | $36 |
| Injection beneath lining of large bowel using a flexible endoscope | 13 | $307 | $24 |
2013: 20 services
| New patient visit (45+ min) | 140 | $18,076 | $129 |
| Removal of polyps or growths in large bowel using an endoscope | 61 | $15,544 | $251 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 96 | $14,390 | $148 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 115 | $12,843 | $108 |
| Imaging of digestive tract done from the inside of the digestive tract | 15 | $11,991 | $799 |
| Short return visit (20+ min) | 154 | $10,596 | $52 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 46 | $10,009 | $218 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 46 | $10,004 | $217 |
| Biopsy of large bowel using a flexible endoscope | 67 | $8,619 | $129 |
| New patient visit (60+ min) | 54 | $8,479 | $157 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 83 | $8,375 | $100 |
| Return visit (30+ min) | 93 | $8,045 | $77 |
| New patient visit (30+ min) | 71 | $5,060 | $71 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $2,870 | $143 |
| Diagnostic exam of large bowel using a flexible endoscope | 15 | $2,596 | $173 |
| Long return visit (40+ min) | 16 | $1,865 | $117 |
| Short return visit | 39 | $1,363 | $34 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,073 | $56 |
| Dilation of esophagus | 25 | $905 | $36 |
| Injection beneath lining of large bowel using a flexible endoscope | 13 | $306 | $24 |
Drugs they prescribed that Part D paid
$187,620
Pharmacies billed $187,620 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 679) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
537 generic and 142 brand-name prescriptions · $187,620 in drug cost · 52 antibiotic prescriptions to 25 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xifaxan | 13 | $40,472 | $3,113 |
| Linzess | 24 | $25,515 | $1,063 |
| Ursodiol | 29 | $8,778 | $303 |
| Sodium Chloride | 54 | $4,767 | $88 |
| Dexlansoprazole Dr | 15 | $4,353 | $290 |
See all 15 drugs
| Xifaxan | 13 | $40,472 | $3,113 |
| Linzess | 24 | $25,515 | $1,063 |
| Ursodiol | 29 | $8,778 | $303 |
| Sodium Chloride | 54 | $4,767 | $88 |
| Dexlansoprazole Dr | 15 | $4,353 | $290 |
| Omeprazole | 172 | $1,936 | $11 |
| Famotidine | 69 | $1,017 | $15 |
| Cholestyramine | 22 | $1,013 | $46 |
| Pantoprazole | 68 | $911 | $13 |
| Spironolactone | 15 | $327 | $22 |
| Clarithromycin | 11 | $168 | $15 |
| Furosemide | 20 | $110 | $6 |
| Ondansetron | 11 | $60 | $5 |
| Amoxicillin | 11 | $44 | $4 |
| Metoclopramide | 11 | $29 | $3 |
Year by year
| 2024 | 679 | 221 | 0% (0) | 21% | $187,620 |
| 2023 | 739 | 229 | None | 19% | $118,477 |
| 2022 | 739 | 223 | None | 17% | $191,337 |
| 2021 | 845 | 264 | None | 24% | $202,446 |
| 2020 | 762 | 251 | None | None | $278,934 |
| 2019 | 615 | 231 | 0% (0) | 19% | $285,438 |
| 2018 | 692 | 260 | 0% (0) | 16% | $165,933 |
| 2017 | 761 | 294 | None | None | $463,141 |
| 2016 | 743 | 332 | None | 15% | $856,363 |
| 2015 | 814 | 338 | None | None | $1,514,001 |
| 2014 | 870 | 432 | None | 26% | $330,547 |
| 2013 | 1,141 | 492 | None | 34% | $179,765 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 16 drugs
| Linzess | 14 | $15,681 | $1,120 |
| Ursodiol | 35 | $12,704 | $363 |
| Dexlansoprazole Dr | 11 | $4,753 | $432 |
| Sodium Chloride | 81 | $4,334 | $54 |
| Omeprazole | 177 | $1,962 | $11 |
| Pantoprazole | 102 | $1,715 | $17 |
| Famotidine | 51 | $975 | $19 |
| Cholestyramine | 23 | $922 | $40 |
| Amitriptyline | 22 | $439 | $20 |
| Spironolactone | 13 | $270 | $21 |
| Metoclopramide | 28 | $238 | $9 |
| Nortriptyline | 12 | $194 | $16 |
| Nystatin | 12 | $152 | $13 |
| Metronidazole | 13 | $129 | $10 |
| Furosemide | 15 | $125 | $8 |
| Ondansetron | 12 | $103 | $9 |
2022: 12 drugs
| Linzess | 30 | $23,014 | $767 |
| Ursodiol | 18 | $9,854 | $547 |
| Sodium Chloride | 56 | $2,793 | $50 |
| Cholestyramine | 29 | $2,058 | $71 |
| Pantoprazole | 120 | $1,912 | $16 |
| Omeprazole | 191 | $1,638 | $9 |
| Famotidine | 51 | $469 | $9 |
| Prednisone | 12 | $452 | $38 |
| Spironolactone | 12 | $290 | $24 |
| Metoclopramide | 33 | $250 | $8 |
| Amitriptyline | 16 | $201 | $13 |
| Metronidazole | 12 | $102 | $9 |
2021: 17 drugs
| Xifaxan | 22 | $75,890 | $3,450 |
| Linzess | 42 | $35,348 | $842 |
| Dexilant | 18 | $13,705 | $761 |
| Creon | 17 | $11,158 | $656 |
| Ursodiol | 15 | $7,569 | $505 |
| Trulance | 12 | $5,974 | $498 |
| Lubiprostone | 11 | $4,993 | $454 |
| Cholestyramine | 39 | $3,598 | $92 |
| Pantoprazole | 155 | $2,372 | $15 |
| Omeprazole | 185 | $2,196 | $12 |
| Sodium Chloride | 55 | $1,448 | $26 |
| Lansoprazole | 12 | $506 | $42 |
| Metoclopramide | 40 | $404 | $10 |
| Amitriptyline | 19 | $249 | $13 |
| Famotidine | 20 | $226 | $11 |
| Metronidazole | 18 | $183 | $10 |
| Nystatin | 13 | $169 | $13 |
2020: 16 drugs
| Xifaxan | 28 | $103,577 | $3,699 |
| Linzess | 14 | $10,834 | $774 |
| Ursodiol | 21 | $10,598 | $505 |
| Dexilant | 21 | $9,885 | $471 |
| Amitiza | 13 | $9,741 | $749 |
| Zenpep | 16 | $5,446 | $340 |
| Omeprazole | 169 | $2,279 | $13 |
| Cholestyramine | 19 | $1,717 | $90 |
| Pantoprazole | 123 | $1,618 | $13 |
| Sodium Chloride | 53 | $1,598 | $30 |
| Metoclopramide | 41 | $467 | $11 |
| Dicyclomine | 19 | $364 | $19 |
| Famotidine | 18 | $229 | $13 |
| Amitriptyline | 15 | $227 | $15 |
| Metronidazole | 24 | $179 | $7 |
| Nystatin | 11 | $171 | $16 |
2019: 14 drugs
| Ursodiol | 17 | $10,601 | $624 |
| Dexilant | 19 | $7,586 | $399 |
| Zenpep | 11 | $3,679 | $334 |
| Cholestyramine | 23 | $2,462 | $107 |
| Omeprazole | 138 | $1,731 | $13 |
| Sodium Chloride | 35 | $1,301 | $37 |
| Pantoprazole | 92 | $1,158 | $13 |
| Diphenoxylate-Atropine | 12 | $1,013 | $84 |
| Lansoprazole | 11 | $587 | $53 |
| Ranitidine | 26 | $447 | $17 |
| Nystatin | 16 | $275 | $17 |
| Metoclopramide | 26 | $251 | $10 |
| Metronidazole | 12 | $143 | $12 |
| Famotidine | 11 | $140 | $13 |
2018: 17 drugs
| Xifaxan | 20 | $51,376 | $2,569 |
| Ursodiol | 23 | $13,824 | $601 |
| Mesalamine | 12 | $9,051 | $754 |
| Linzess | 21 | $8,739 | $416 |
| Esomeprazole Magnesium | 15 | $3,336 | $222 |
| Omeprazole | 150 | $2,481 | $17 |
| Pantoprazole | 90 | $1,328 | $15 |
| Ranitidine | 62 | $1,075 | $17 |
| Diphenoxylate-Atropine | 12 | $755 | $63 |
| Polyethylene Glycol 3350 | 40 | $396 | $10 |
| Spironolactone | 11 | $224 | $20 |
| Famotidine | 12 | $216 | $18 |
| Dicyclomine | 18 | $201 | $11 |
| Nystatin | 14 | $183 | $13 |
| Metronidazole | 20 | $172 | $9 |
| Metoclopramide | 14 | $97 | $7 |
| Furosemide | 11 | $61 | $6 |
2017: 18 drugs
| Xifaxan | 26 | $52,360 | $2,014 |
| Lialda | 22 | $27,234 | $1,238 |
| Linzess | 13 | $5,387 | $414 |
| Esomeprazole Magnesium | 15 | $4,633 | $309 |
| Mercaptopurine | 17 | $3,128 | $184 |
| Omeprazole | 202 | $2,977 | $15 |
| Ranitidine | 64 | $1,158 | $18 |
| Pantoprazole | 47 | $776 | $17 |
| Diphenoxylate-Atropine | 13 | $546 | $42 |
| Polyethylene Glycol 3350 | 44 | $489 | $11 |
| Ondansetron | 20 | $251 | $13 |
| Spironolactone | 12 | $215 | $18 |
| Metronidazole | 19 | $202 | $11 |
| Nystatin | 14 | $193 | $14 |
| Gavilyte-G | 11 | $133 | $12 |
| Famotidine | 14 | $75 | $5 |
| Metoclopramide | 11 | $71 | $6 |
| Furosemide | 13 | $48 | $4 |
2016: 16 drugs
| Harvoni | 15 | $478,164 | $31,878 |
| Lialda | 12 | $17,495 | $1,458 |
| Mercaptopurine | 19 | $2,906 | $153 |
| Omeprazole | 211 | $2,841 | $13 |
| Cholestyramine | 22 | $1,920 | $87 |
| Polyethylene Glycol 3350 | 100 | $1,568 | $16 |
| Ranitidine | 23 | $921 | $40 |
| Pantoprazole | 33 | $516 | $16 |
| Diphenoxylate-Atropine | 12 | $490 | $41 |
| Amitriptyline | 17 | $315 | $19 |
| Nystatin | 11 | $230 | $21 |
| Spironolactone | 16 | $193 | $12 |
| Gavilyte-G | 13 | $178 | $14 |
| Metronidazole | 19 | $169 | $9 |
| Metoclopramide | 27 | $136 | $5 |
| Trazodone | 12 | $96 | $8 |
2015: 13 drugs
| Harvoni | 35 | $1,124,921 | $32,141 |
| Nexium | 12 | $8,249 | $687 |
| Mercaptopurine | 17 | $2,485 | $146 |
| Ribasphere | 19 | $2,459 | $129 |
| Omeprazole | 187 | $2,027 | $11 |
| Polyethylene Glycol 3350 | 144 | $1,861 | $13 |
| Pantoprazole | 33 | $507 | $15 |
| Diphenoxylate-Atropine | 12 | $448 | $37 |
| Amitriptyline | 22 | $248 | $11 |
| Metoclopramide | 30 | $189 | $6 |
| Metronidazole | 20 | $184 | $9 |
| Promethazine | 15 | $157 | $10 |
| Prochlorperazine Maleate | 12 | $94 | $8 |
2014: 13 drugs
| Nexium | 40 | $20,810 | $520 |
| Lialda | 14 | $17,197 | $1,228 |
| Amitiza | 20 | $8,389 | $419 |
| Suprep | 59 | $4,565 | $77 |
| Omeprazole | 211 | $2,686 | $13 |
| Polyethylene Glycol 3350 | 149 | $1,990 | $13 |
| Mercaptopurine | 21 | $1,861 | $89 |
| Pantoprazole | 35 | $617 | $18 |
| Diphenoxylate-Atropine | 19 | $565 | $30 |
| Peg-3350 and Electrolytes | 17 | $264 | $16 |
| Promethazine | 21 | $244 | $12 |
| Metronidazole | 15 | $141 | $9 |
| Metoclopramide | 13 | $76 | $6 |
2013: 24 drugs
| Nexium | 46 | $21,285 | $463 |
| Amitiza | 58 | $16,843 | $290 |
| Lialda | 13 | $14,809 | $1,139 |
| Suprep | 109 | $7,957 | $73 |
| Dexilant | 14 | $3,864 | $276 |
| Omeprazole | 213 | $3,700 | $17 |
| Mercaptopurine | 17 | $2,256 | $133 |
| Lansoprazole | 17 | $1,515 | $89 |
| Peg-3350 and Electrolytes | 92 | $1,503 | $16 |
| Polyethylene Glycol 3350 | 41 | $1,372 | $33 |
| Cholestyramine | 13 | $787 | $61 |
| Peg 3350-Electrolyte | 34 | $386 | $11 |
| Pantoprazole | 32 | $367 | $11 |
| Gavilyte-C | 24 | $344 | $14 |
| Gavilyte-G | 23 | $338 | $15 |
| Diphenoxylate-Atropine | 13 | $237 | $18 |
| Metronidazole | 15 | $183 | $12 |
| Metoclopramide | 26 | $166 | $6 |
| Loperamide | 12 | $163 | $14 |
| Dicyclomine | 13 | $138 | $11 |
| Amitriptyline | 24 | $114 | $5 |
| Promethazine | 11 | $114 | $10 |
| Lisinopril | 12 | $94 | $8 |
| Prednisone | 11 | $76 | $7 |
Money from drug and device companies
$2,448 in 2025
| 2025 | 14 | 96 | None | $2,448 |
| 2024 | 15 | 86 | None | $1,916 |
| 2023 | 13 | 59 | None | $1,123 |
| 2022 | 10 | 19 | None | $370 |
| 2021 | 5 | 11 | None | $289 |
| 2020 | 5 | 7 | None | $131 |
| 2019 | 11 | 18 | None | $446 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | General - Therapies | $1,101 | 11 payments
|
| Abbvie | Rinvoq | $565 | 33 payments
|
| Aimmune Therapeutics | Vowst | $265 | 32 payments
|
| Gilead Sciences | Livdelzi | $119 | 1 payment
|
| Madrigal Pharmaceuticals | Rezdiffra | $82 | 3 payments
|
| Ipsen Biopharmaceuticals | Iqirvo | $73 | 3 payments
|
See all 96 published payments
| Abbvie | Meals · 2025-12-18 | Rinvoq | $21 |
| Abbvie | Meals · 2025-12-17 | Mavyret | $14 |
| Pfizer | Meals · 2025-12-15 | Velsipity | $17 |
| Aimmune Therapeutics | Meals · 2025-12-09 | Vowst | $8 |
| Abbvie | Meals · 2025-12-04 | Creon | $26 |
| Aimmune Therapeutics | Meals · 2025-12-02 | Vowst | $12 |
| Phathom Pharmaceuticals | Meals · 2025-12-01 | Voquezna | $18 |
| Aimmune Therapeutics | Meals · 2025-11-18 | Vowst | $12 |
| Aimmune Therapeutics | Meals · 2025-11-18 | Vowst | $24 |
| Abbvie | Meals · 2025-11-17 | Linzess | $2 |
| Novo Nordisk | Meals · 2025-11-16 | Wegovy | $20 |
| Abbvie | Meals · 2025-11-12 | Rinvoq | $26 |
| Abbvie | Meals · 2025-11-11 | Rinvoq | $19 |
| Janssen Biotech | Meals · 2025-11-08 | Tremfya | $22 |
| Phathom Pharmaceuticals | Meals · 2025-11-05 | Voquezna | $14 |
| Abbvie | Meals · 2025-11-04 | Linzess | $22 |
| Aimmune Therapeutics | Meals · 2025-11-04 | Vowst | $11 |
| Aimmune Therapeutics | Meals · 2025-10-30 | Vowst | $6 |
| Ipsen Biopharmaceuticals | Meals · 2025-10-27 | Iqirvo | $31 |
| Abbvie | Meals · 2025-10-23 | Rinvoq | $10 |
| Aimmune Therapeutics | Meals · 2025-10-23 | Vowst | $5 |
| Abbvie | Meals · 2025-10-14 | Rinvoq | $22 |
| Aimmune Therapeutics | Meals · 2025-10-14 | Vowst | $7 |
| Abbvie | Meals · 2025-10-09 | Rinvoq | $9 |
| Abbvie | Meals · 2025-10-06 | Linzess | $7 |
| Aimmune Therapeutics | Meals · 2025-09-25 | Vowst | $6 |
| Abbvie | Meals · 2025-09-24 | Linzess | $26 |
| Aimmune Therapeutics | Meals · 2025-09-23 | Vowst | $9 |
| Abbvie | Meals · 2025-09-17 | Linzess | $22 |
| Aimmune Therapeutics | Meals · 2025-09-16 | Vowst | $11 |
| Abbvie | Meals · 2025-09-11 | Rinvoq | $19 |
| Aimmune Therapeutics | Meals · 2025-09-04 | Vowst | $10 |
| Abbvie | Meals · 2025-08-29 | Linzess | $22 |
| Abbvie | Meals · 2025-08-26 | Skyrizi | $14 |
| Abbvie | Meals · 2025-08-25 | Skyrizi | $1 |
| Lilly USA | Meals · 2025-08-21 | Omvoh | $22 |
| Aimmune Therapeutics | Meals · 2025-08-21 | Vowst | $4 |
| Micro-tech Endoscopy USA | Meals · 2025-08-20 | Riteclip | $14 |
| Abbvie | Meals · 2025-08-14 | Rinvoq | $21 |
| Abbvie | Meals · 2025-08-13 | Rinvoq | $21 |
| Aimmune Therapeutics | Meals · 2025-08-12 | Vowst | $10 |
| Ipsen Biopharmaceuticals | Meals · 2025-08-08 | Iqirvo | $15 |
| Abbvie | Meals · 2025-07-31 | Rinvoq | $22 |
| Abbvie | Meals · 2025-07-28 | Creon | $28 |
| Ardelyx | Meals · 2025-07-24 | Ibsrela | $21 |
| Aimmune Therapeutics | Meals · 2025-07-15 | Vowst | $7 |
| Abbvie | Meals · 2025-07-11 | Creon | $35 |
| Boston Scientific | Travel · 2025-07-10 | General - Therapies | $437 |
| Boston Scientific | Meals · 2025-07-10 | General - Therapies | $25 |
| Boston Scientific | Travel · 2025-07-10 | General - Therapies | $75 |
| Abbvie | Meals · 2025-07-10 | Rinvoq | $21 |
| Gilead Sciences | Meals · 2025-07-10 | Livdelzi | $119 |
| Abbvie | Meals · 2025-06-26 | Linzess | $15 |
| Abbvie | Meals · 2025-06-26 | Creon | $4 |
| Madrigal Pharmaceuticals | Meals · 2025-06-19 | Rezdiffra | $30 |
| Aimmune Therapeutics | Meals · 2025-06-19 | Vowst | $10 |
| Aimmune Therapeutics | Meals · 2025-06-12 | Vowst | $3 |
| Ipsen Biopharmaceuticals | Meals · 2025-06-09 | Iqirvo | $27 |
| Aimmune Therapeutics | Meals · 2025-06-05 | Vowst | $9 |
| Aimmune Therapeutics | Meals · 2025-06-04 | Vowst | $8 |
| Aimmune Therapeutics | Meals · 2025-05-22 | Vowst | $6 |
| Abbvie | Meals · 2025-05-15 | Rinvoq | $22 |
| Ardelyx | Meals · 2025-05-15 | Ibsrela | $17 |
| Janssen Biotech | Meals · 2025-05-13 | Tremfya | $24 |
| Abbvie | Meals · 2025-05-08 | Rinvoq | $18 |
| Aimmune Therapeutics | Meals · 2025-05-07 | Vowst | $7 |
| Aimmune Therapeutics | Meals · 2025-05-07 | Vowst | $14 |
| Boston Scientific | Meals · 2025-04-25 | Overstitch Endoscopic Suturing System | $75 |
| Aimmune Therapeutics | Meals · 2025-04-25 | Vowst | $4 |
| Boston Scientific | Travel · 2025-04-24 | Overstitch Endoscopic Suturing System | $245 |
| Boston Scientific | Meals · 2025-04-18 | General - Hemostasis | $51 |
| Abbvie | Meals · 2025-04-18 | Skyrizi | $18 |
| Madrigal Pharmaceuticals | Meals · 2025-04-10 | Rezdiffra | $32 |
| Genzyme | Meals · 2025-04-02 | Dupixent | $19 |
| Aimmune Therapeutics | Meals · 2025-03-25 | Vowst | $5 |
| Abbvie | Meals · 2025-03-24 | Mavyret | $16 |
| Boston Scientific | Meals · 2025-03-20 | General - Metal Stents - G.I. | $39 |
| Boston Scientific | Meals · 2025-03-20 | X-Tack Endoscopic Helix Tacking System | $17 |
| Boston Scientific | Meals · 2025-03-18 | X-Tack Endoscopic Helix Tacking System | $52 |
| Aimmune Therapeutics | Meals · 2025-03-18 | Vowst | $10 |
| Abbvie | Meals · 2025-03-17 | Rinvoq | $15 |
| Pfizer | Meals · 2025-02-27 | Xeljanz | $18 |
| Genzyme | Meals · 2025-02-27 | Dupixent | $15 |
| Abbvie | Meals · 2025-02-20 | Rinvoq | $2 |
| Aimmune Therapeutics | Meals · 2025-02-20 | Vowst | $6 |
| Abbvie | Meals · 2025-02-18 | Skyrizi | $21 |
| Abbvie | Meals · 2025-02-18 | Creon | $6 |
| Aimmune Therapeutics | Meals · 2025-02-13 | Vowst | $3 |
| Aimmune Therapeutics | Meals · 2025-02-04 | Vowst | $8 |
| Madrigal Pharmaceuticals | Meals · 2025-01-28 | Rezdiffra | $21 |
| Aimmune Therapeutics | Meals · 2025-01-27 | Vowst | $6 |
| Aimmune Therapeutics | Meals · 2025-01-23 | Vowst | $11 |
| Aimmune Therapeutics | Meals · 2025-01-16 | Vowst | $5 |
| Boston Scientific | Meals · 2025-01-14 | Exalt Model D | $38 |
| Aimmune Therapeutics | Meals · 2025-01-07 | Vowst | $6 |
| Boston Scientific | Meals · 2025-01-03 | General - Biliary Devices | $47 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,916
| Abbvie | Rinvoq | $385 | 25 payments
|
| Boston Scientific | Exalt Model D | $316 | 8 payments
|
| Aimmune Therapeutics | Vowst | $313 | 32 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $177 | 5 payments
|
| Janssen Biotech | Tremfya | $132 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | None | $122 | 1 payment
|
| Ipsen Biopharmaceuticals | Bylvay | $122 | 1 payment
|
| Gilead Sciences | Vemlidy | $122 | 1 payment
|
| Madrigal Pharmaceuticals | Resmetirom | $80 | 3 payments
|
| Pfizer | Xeljanz | $35 | 2 payments
|
| Celltrion USA | Vegzelma | $34 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $25 | 1 payment
|
| Phathom Pharmaceuticals | Voquezna | $19 | 1 payment
|
| Ardelyx | Ibsrela | $18 | 1 payment
|
| Ironwood Pharmaceuticals | Linzess | $15 | 1 payment
|
2023: $1,123
| AbbVie | Viberzi | $260 | 20 payments
|
| Celgene | Zeposia | $228 | 15 payments
|
| Gilead Sciences | Vemlidy | $196 | 5 payments
|
| Boston Scientific | Axios | $150 | 5 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $77 | 4 payments
|
| Pfizer | Velsipity | $54 | 3 payments
|
| Olympus America | Evis Exera III Xenon Light Source | $39 | 1 payment
|
| Merck Sharp & Dohme | Dificid | $29 | 1 payment
|
| Intercept Pharmaceuticals | Ocaliva | $22 | 1 payment
|
| Ultragenyx Pharmaceutical | None | $22 | 1 payment
|
| Ferring Pharmaceuticals | Rebyota | $20 | 1 payment
|
| Nestle Healthcare Nutrition | Vowst | $16 | 1 payment
|
| Micro-tech Endoscopy USA | Lockado | $11 | 1 payment
|
2022: $370
| Boston Scientific | Exalt Model D | $85 | 3 payments
|
| Janssen Biotech | Stelara | $54 | 3 payments
|
| Abbvie | Rinvoq | $52 | 3 payments
|
| Pfizer | Xeljanz | $47 | 3 payments
|
| Gilead Sciences | None | $47 | 2 payments
|
| Daiichi Sankyo | Injectafer | $23 | 1 payment
|
| Celgene | Zeposia | $19 | 1 payment
|
| Nestle HealthCare Nutrition | Zenpep | $16 | 1 payment
|
| Ferring Pharmaceuticals | None | $14 | 1 payment
|
| Ironwood Pharmaceuticals | Linzess | $12 | 1 payment
|
2021: $289
| Boston Scientific | Exalt | $162 | 4 payments
|
| AbbVie | Creon | $64 | 3 payments
|
| Gilead Sciences | None | $39 | 2 payments
|
| Pfizer | Xeljanz | $13 | 1 payment
|
| Ironwood Pharmaceuticals | Linzess | $12 | 1 payment
|
2020: $131
| AbbVie | Humira | $38 | 2 payments
|
| Ironwood Pharmaceuticals | Linzess | $37 | 2 payments
|
| Intercept Pharmaceuticals | Ocaliva | $24 | 1 payment
|
| Boston Scientific | General - Biliary Devices | $18 | 1 payment
|
| Ferring Pharmaceuticals | Clenpiq | $15 | 1 payment
|
2019: $446
| Janssen Scientific Affairs | Stelara | $125 | 1 payment
|
| Janssen Biotech | Stelara | $58 | 3 payments
|
| AbbVie | Humira | $56 | 3 payments
|
| Allergan | Linzess | $44 | 2 payments
|
| Shire North American Group | Gattex | $34 | 2 payments
|
| Boston Scientific | General - Gi Dilatation | $34 | 1 payment
|
| Pfizer | Xeljanz | $28 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Motegrity | $21 | 1 payment
|
| Shionogi | Symproic | $16 | 1 payment
|
| Gilead Sciences | None | $15 | 1 payment
|
| Ferring Pharmaceuticals | Clenpiq | $15 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 85.8 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1538253190
- Licence
- CA A45775California A45775: Current · expires 2029-01-31
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00A457750
- Taxonomy
- Federal specialty code 174400000X (174400000X)
- Mailing address
- 1099 E Champlain Dr # 134a, Fresno, CA, 93720
- NPI first listed
- 2006-10-03
- NPI last updated
- 2015-02-12
This is when the NPI record was last certified, not a medical board exam.